Sightpath Medical to Mobilize Femtosecond Laser for Cataract Surgery

Sightpath Medical, a provider of mobile and fixed ophthalmic surgical solutions, has announced the launch of its new mobile femtosecond laser for cataract service in early 2013.

Advertisement

This new MoFeTM service suite will include a femtosecond laser, an intra-operative wavefront aberrometer and a certified laser engineer, offered on a stop fee and variable cost basis. A nationwide roll-out is planned throughout 2013.

Sightpath Medical is known for mobilizing sensitive, high technology devices for ophthalmology and uses a patented air-ride and climate controlled system to transport its equipment. Its current fleet includes more than two hundred femtosecond, Excimer, Wavescan, YAG and SLT lasers, coupled with a full staff of certified laser engineers and technicians.

Related Articles on Ophthalmology:
Moran Eye Center Donates Free Surgery
Bausch & Lomb Acquires German Laser Maker Technolas Perfect Vision
Ophthalmic Consultants of Long Island to Offer Implantable Telescope Surgery

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in Ophthalmology

  • East Lansing-based Michigan Surgical Center has disclosed a data breach that may have exposed personal information, according to a July…

  • Cincinnati-based MidWest Eye Center welcomed Alec Bradley, MD, an ophthalmologist who specializes in premium cataract surgery, refractive surgery, microinvasive glaucoma…

Advertisement

Comments are closed.